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Background: Postmenopausal women experience adverse physiological changes caused by estrogen deprivation. Here,
we hypothesized that the administration of isoflavone, a phytoestrogn, and/or physical exercise could reverse changes
in the levels of hepatic enzymes disturbed by loss of estrogen to ameliorate postmenopause-related health problems.
Methods: Thirty-week-old female Sprague–Dawley rats were divided into five groups: a sham-operated (SHAM) group,
ovariectomized groups on a regular diet with exercise (EXE) and without exercise (OVX), and ovariectomized groups on
an isoflavone supplemented diet with (ISO + EXE) and without exercise (ISO). Proteomic tools were employed to identify
candidate hepatic proteins that were differentially expressed among the five animal groups.
Results: INMT was detected in the SHAM but not in all of the ovariectomized rats. Seven proteins (PPIA, AKR1C3,
ALDH2, PSME2, BUCS1, OTC, and GAMT) were identified to have differential expression among the groups. When
compared to the SHAM group, the ovariectomy elevated the levels of PPIA, BUCS1, PSME2, AKR1C3, and GAMT while
decreasing ALDH2 and OTC. Among these OVX-induced changes, OVX-increased BUCS1 and GAMT levels were
noticeably decreased by ISO or EXE and further greatly down-regulated by ISO + EXE. In the case of PSME2, ISO and EXE
further increased OVX-upregulated expression levels but ISO + EXE greatly reduced OVX-increased levels. On the other
hand OVX-lowered OTC levels were elevated by ISO, EXE, or ISO + EXE. The protein levels of ALDH2, PPIA, and AKR1C3
were not significantly reverted by ISO, EXE or ISO + EXE.
Conclusion: The combination of an isoflavone diet and exercise partly reversed ovariectomy-induced changes in hepatic
protein expression levels. Our data suggest that the combinatory regimen of isoflavone supplementation and exercise
may be beneficial to menopausal women through modulating hepatic protein expression profiles.
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Postmenopausal women experience physiological chan-
ges related to estrogen deprivation. For example, de-
creased circulating estrogen levels have shown to be
associated with menopausal metabolic syndrome with
increasing adiposity [1]. In a rat model of metabolic syn-
drome, ovariectomy worsened its symptoms [2]. Low es-
trogen levels can also result in systemic inflammation in* Correspondence: leeseungmin@yonsei.ac.kr
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reproduction in any medium, provided the orpostmenopausal women [3]. Besides these physiological
changes, postmenopausal women also show a reduction
in lean body mass, which can partly be explained by in-
sufficient estrogen levels [4]. Estrogen replacement ther-
apy has been attempted to reverse the changes caused
by menopause in an effort to decrease its cardiovascular
and thrombotic risks [5] and to preserve bone mineral
density [6]. It appears that estrogen plays several signifi-
cant roles in women’s health.
Despite its many advantages, estrogen therapy is cau-
tiously prescribed to postmenopausal women due to the
possible increase in the risk of developing endometrialtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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with isoflavones, natural plant substances, has been at-
tempted to mimic the effects of estrogen in postmeno-
pausal women [7]. Genistein, a type of isoflavone, was
demonstrated to be efficacious in coping with estro-
gen deprivation [8-10]. While providing protective ef-
fects against the loss of estrogen, isoflavones also
delivered some level of protection against hormone-
responsive diseases such as breast and prostate can-
cers [11]. The frequent consumption of soy products,
which are rich in isoflavones, has been shown to be
related with a lower prevalence of breast cancer [12].
In addition to providing estrogen-like activity, the
high intake of dietary isoflavone also reduced the
risks of developing metabolic disorders including car-
diovascular diseases, diabetes, and obesity compared
to the high intake of animal products [13-16]. In
particular, postmenopausal women with type 2 dia-
betes who received dietary isoflavone supplementation
showed significantly reduced fasting insulin levels, in-
dicating improvement in their insulin resistance [17].
Exercise is another lifestyle factor that can easily be
modulated to improve lipid profiles. Postmenopausal
women are advised to exercise in order to reduce abdo-
minal adiposity, which increases after menopause [18],
and to preserve muscle mass [19]. Exercise was also
shown to be effective in reducing systemic and low-grade
inflammation [20], which is a hallmark of chronic meta-
bolic disorders. When provided with an exercise inter-
vention, postmenopausal women were shown to have
successfully lowered their levels of c-reactive peptide,
which indicated diminished systemic inflammation [21].
Despite the many health benefits of exercise for postmen-
opausal women [18-20], exercise can also increase the
production of free radicals that damage tissue [22].
Our group has previously reported that ovariecto-
mized rats that underwent an exercise intervention had
significantly elevated DNA damage in their lymphocytes
compared to those that did not receive exercise [23].
Therefore, even if exercise interventions could lower
blood LDL-cholesterol and the atherogenic index, the
exercise may need to be monitored to minimize possible
DNA damage in cases of estrogen deficiency [23]. The
amount of free radicals generated by exercise may be
lowered by isoflavone supplementation [23] because iso-
flavone possesses strong antioxidant properties and can
scavenge reactive oxygen species [24]. Indeed, postme-
nopausal women who consumed isoflavones showed de-
creased levels of serum F2-isoprostanes, indicators of
oxidative stress, suggesting a role of isoflavones as anti-
oxidants [13,25]. Furthermore, isoflavone and exercise
were shown to have a synergistic effect in ovariectomized
mice, increasing their lean body mass apart from lowering
body fat mass [19]. However mechanistic aspects of theisoflavone supplementation along with exercise in terms
of the regulation of gene expression related to these bene-
ficial effects have not been elucidated.
Considering that the liver plays a key role in metaboliz-
ing nutrients, hormones, and toxicants, protein expression
patterns in the liver could reflect diverse changes in the
systemic regulation of metabolism. To gain an insight into
global changes in the gene expression upon isoflavone sup-
plementation and/or exercise, we utilized a non-hypothesis
driven proteomic approach. We hypothesized that an
isoflavone-supplemented diet in combination with exercise
could modulate the menopause-induced changes in hep-
atic protein abundance back towards its state prior to the
onset of menopause. We compared the changes in all of
the protein expression levels according to isoflavone sup-
plementation and/or exercise regimen. The hepatic protein
expression patterns among the following five different
groups were compared: sham-operated (SHAM), ovariec-
tomized only (OVX), ovariectomized and then isoflavone-
supplemented (ISO), ovariectomized and then exercised
(EXE), and ovariectomized, isoflavone-supplemented, and
exercised (ISO + EXE).
Methods
Animals
Thirty-week-old female Sprague–Dawley (SD) rats were
purchased from the Korea Food and Drug Administration,
Laboratory Animal Resources Division (Seoul, Korea).
The animals were individually housed in a room that was
maintained at 22 ± 1°C with 55 ± 3% humidity under a
controlled 12 h/12 h light–dark cycle. A total of forty rats
fed on a chow diet were randomly divided into five groups
and were allowed to adjust to the housing environment
for one week. Then one group was sham-operated on
(SHAM; n = 8) and the remaining four groups (OVX, ISO,
EXE, and ISO-EXE; n = 8 each) were ovariectomized. Af-
ter two weeks of recovery, SHAM, OVX and EXE groups
were put on a basal AIN76A diet whereas ISO and ISO +
EXE groups were put on an isoflavone diet, which is an
AIN76A diet supplemented with 0.76 g of isoflavones per
100 g of diet. All animals were fed for 12 weeks ad li-
bitum. As for treadmill exercise for 12 weeks, the EXE
group and the ISO + EXE group exercised four times a
week on a treadmill. Before starting their exercise regimen
the animals in the EXE and ISO-EXE groups were accus-
tomed to running on a motor-driven treadmill. During the
first week, the rats ran at a speed of 10 m/min on a tread-
mill without an incline for 10 min on each day of exercise.
The rats were subsequently trained to run at a speed of
16 ~ 17 m/min for 20 min during the second week and
then again at this pace for 30 min from the third week
until the end of their exercise regimen [23]. The Commit-
tee on Animal Experimentation and Ethics of Yonsei Uni-
versity approved the animal protocols used in the study.
Yoon et al. Journal of the International Society of Sports Nutrition 2014, 11:29 Page 3 of 8
http://www.jissn.com/content/11/1/29At the end of the experiment, the animals were eutha-
nized by cardiac puncture under ketamine anesthesia.
The liver of the rats was removed and a portion of the
tissue was transferred into a plain plastic tube which was
snap-frozen in liquid nitrogen. The liver samples were
kept at −80°C until use.
Sample preparation
Frozen liver tissue samples were homogenized in extrac-
tion buffer consisting of 7 M urea, 2 M thiourea, 4.5%
(w:v) 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-pro-
panesulfonate (CHAPS), 40 mM Tris, 100 mM dithioer-
ythryol (DTE), 0.5% carrier ampholytes, and a protease
inhibitor cocktail (Sigma Aldrich, St. Louis, USA). The
homogenate was centrifuged at 45,000 rpm for 45 min
to remove tissue and cellular debris. The supernatants
were collected and stored at −70°C. Protein concen-
trations of the tissue lysates were measured using the
Bradford method.
Two dimensional electrophoresis (2-DE) and image
analysis
The samples were diluted to 350 μl with rehydration
solution [9 M urea, 4% CHAPS, 100 mM dithiothreitol
(DTT), 0.5% (v/v) IPG buffer, and trace amount of bro-
mophenol blue]. Isoelectric focusing (IEF) was performed
to separate proteins according to their isoelectric points
using IPG strips (non-linear pH 3–10, Amersham Biosci-
ences, UK) and Multiphor II, an apparatus designed for
IEF analysis (Amersham-Pharmacia, Amersham, UK). The
IPG strips were initially incubated overnight in a rehydra-
tion solution. Samples were then loaded onto IPG strips
and IEF was performed at 20°C with a current of 0.05 mA
for a total of 85 kVh. The IPG strips were equilibrated to
reduce the disulfide linkages through the addition of
10 ml of equilibrating solution containing isopropanol and
2.6% tributyl phosphine (Fluka) and then were gently
rocked for 25 min. Second-dimension electrophoresis was
performed using 9-16% gradient gels and the Iso-DALT
apparatus (Hoefer Scientific Instruments, San Francisco,
CA), and was then stopped when the tracking dye reached
the anode end of the gels.
The 2-DE gels were visualized by silver staining and
scanned using a GS800 photometer (Bio-Rad). The digi-
tized 2-DE gel images were analyzed with PDQUEST
(GenBio, Geneva, Switzerland) and compared by the mat-
ching method. Differentially expressed spots were selected
based on a minimum two-fold difference between the
groups.
In-gel tryptic digestion
Candidate spots were excised from the stained gel, des-
tained with 0.1 M ammonium bicarbonate in 50% ace-
tonitrile (Sigma), and dried using a SpeedVac SC110(SavantHolbook, HY). The excised and dried gel was rehy-
drated in a solution containing 1 M DTT and 0.1 M am-
monium bicarbonate (pH 7.8) at 56°C for 30 min. The
gels were subsequently incubated in a solution containing
1% iodoacetamide and 0.1 M ammonium bicarbonate
(pH 7.8) for an additional 30 min in the dark. Next, the
gels were washed with 0.1 M ammonium bicarbonate in
50% acetonitrile and dried. The gels were then rehydrated
and incubated in trypsin solution (Promega, Madison,
WI) overnight at 37°C. The trypsinized peptide solutions
were sonicated for 30 min.
Matrix-assisted laser desorption/ionisation-time of flight
mass spectrometry (MALDI-TOF MS)
The peptides generated by in-gel digestion were subjec-
ted to a desalting and concentration step on a μZipTipC18
column (Millipore, Bedford, MA). The peptide mix-
tures were analyzed using MALDI-TOF MS (Applied
Biosystems, CA). 0.5 ml of digested peptide was placed
on a MALDI sample plate with 0.5 ml of matrix solu-
tion. Analysis was performed on a Perseptive Biosystem
Voyager-DE STR (Perseptive Biosystems, MA). Internal
mass calibration was performed using autolytic fragments
derived from trypsin digestion. Proteins were identified by
peptide mass fingerprinting (PMF) with the search engine
program MASCOT and ProFound. All searches were per-
formed using a mass window between 0 and 100 kDa. The
criteria for positive identification of proteins were set as
follows: (i) at least four matching peptide masses, (ii)
50 ppm or better mass accuracy, and (iii) the Mr and pI of
the identified proteins matched the estimated values ob-
tained from image analysis.
Results
Proteomic comparison of hepatic protein expressions
among the animal groups
Hepatic protein profiles in the animal groups are shown
in Figure 1. After analyzing the gel images, differentially
expressed spots were selected when their normalized
spot intensities between the groups showed at least
two-fold differences. The normalized protein spot in-
tensities are presented in Figure 2. The proteins iden-
tified with differential expression levels are listed in
Table 1. We identified eight differentially expressed pro-
teins, which were spot number 5503 (Indolethylamine
N-methyltransferase, INMT), 8203 (Cyclophilin A/pepti-
dylprolyl isomerase A, PPIA), 3607 (butyryl coenzyme A
synthetase 1, BUCS1), 5701 (proteasome activator rPA28
subunit beta, PSME2), 8002 (3 alpha-hydroxysteroid
dehydrogenase, AKR1C3), 6601 (guanidinoacetate N-
methyltransferase, GAMT), 9401 (aldehyde dehydro-
genase, mitochondrial, ALDH2, and 9801 (ornithine
carbamoyltransferase, OTC). The experimental ratios of
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Figure 1 Two-dimensional gel image analysis of the livers of ovariectomized rats following isoflavone supplementation and exercise.
Statistically significant spots are indicated by arrows in each gel. (A) SHAM group, sham-operated. (B) OVX group, ovariectomized. (C) ISO group,
ovariectomized and provided isoflavone supplementation. (D) EXE group, ovariectomized and provided exercise training. (E) ISO + EXE group,
ovariectomized and provided isoflavone supplementation and exercise training.
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proteins by our proteomic method was reliable. The se-
quence coverage is the percentage of the database protein
sequence matched by the peptides identified in the prote-
omics. Our sequence coverage ranged from 9 to 71% for
the identified proteins.Sham 1.00 1.00 1.00 1.00
OVX 2.83 0.65 5.86 3.93
ISO 4.56 0.69 3.23 4.22
EXE 2.76 0.22 3.35 8.83
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Figure 2 Comparisons of protein spots differentially expressed in the
The normalized intensities of the protein spots in the five animal groups arComparison of hepatic protein expressions between
sham-operated and ovariectomized rats
Hepatic protein profiles for each SHAM and OVX group
are shown in Figure 1A and B. Spot number 5503
(INMT) was detected in the SHAM but not in any of the
other ovariectomized groups (Figure 2). On the other1.00 1.00 1.00 1.00
3.61 0.19 2.57 0.00
5.66 0.56 2.07 0.00
7.62 0.43 1.79 0.00
3.05 0.29 1.63 0.00
SO EXE ISO+EXE
AKR1C3 OTC GAMT INMT
livers of ovariectomized rats after isoflavone intake and exercise.
e shown.













8203 NP_058797 PPIA Peptidyl-prolyl cis-trans isomerase A 18.1/8.34 17.5/9.0 86 71
9401 P81178 ALDH2 Aldehyde dehydrogenase, mitochondrial 54.8/5.83 46.4/6.6 298 12
3607 NP_001101972 BUCS1 Butyryl Coenzyme A synthetase 1 27.8/5.57 50.1/5.1 39 13
5701 BAA08207 PSME2 Proteasome activator rPA28 subunit beta 27.1/5.52 30.1/5.3 75 13
8002 AAB19918 AKR1C3 3 alpha-hydroxysteroid dehydrogenase 37.6/7.03 36.1/7.4 121 9
9801 AAA41769 OTC Ornithine carbamoyltransferase 39.9/9.1 52.1/7.8 220 14
5503 NP_001102492 INMT Indolethylamine N-methyltransferase 30/5.7 29.3/5.4 99 12
6601 NP_036925 GAMT Guanidinoacetate N-methyltransferase 26.7/5.69 28.2/5.8 48 16
aScore is −10xlog(P), where P is the probability that the observed match is a random event, based on the NCBInr database using the MASCOT searching program
as MS/MS data.
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demonstrated an increase in protein levels, which were
spot numbers 8203 (PPIA, 2.83 fold up), 3607 (BUCS1,
5.86 fold up), 5701 (PSME2, 3.93 fold up), 8002 (AKR1C3,
3.61 fold up), and 6601 (GAMT, 2.57 fold up). Two pro-
tein spots were down-regulated in ovariectomized rats
when compared to the SHAM group, which include spot
numbers 9401 (ALDH2, 1.54 fold down) and 9801 (OTC,
5.26 fold down).
Effects of isoflavone supplementation on the levels of
hepatic protein expression in ovariectomized rats
We also determined if isoflavone supplementation could
affect protein expression patterns in ovariectomized
rats. The expression of hepatic proteins in ovariecto-
mized rats on an isoflavone-supplemented diet (ISO)
was compared with that of the OVX group (Figure 1B and
C). Isoflavone-supplementation resulted in the down-
regulation of spot number 3607 (BUCS1, a 1.82 fold
down) and the up-regulation of spot numbers 8203
(PPIA, 1.61 fold up), 8002 (AKR1C3, a 1.57 fold up),
and 9801 (OTC, 2.95 fold up) compared to the rats with-
out isoflavone supplementation (Figure 2). Spot numbers
9401 (ALDH2), 5701 (PSME2), 6601 (GAMT), and 5503
(INMT) did not change after isoflavone supplementation
(Figure 2).
Effects of exercise on the levels of hepatic protein
expressions in ovariectomized rats
The influence of physical exercise was also examined in
ovariectomized rats (Figure 1B and D). The animals that
underwent regular exercise (EXE) demonstrated an up-
regulation of spot numbers 5701 (PSME2, 2.25 fold up),
8002 (AKR1C3, 2.11 fold up), and 9801 (OTC, 2.26 fold
up) in comparison with the OVX group. However, the
EXE group showed a reduction in the protein expression
levels of spot numbers 9401 (ALDH2, 2.95 fold down),
3607 (BUCS1, 1.75 fold down) and 6601 (GAMT, 1.44fold down) compared to the OVX group. Exercise did not
affect the expression of protein spot 8203 (PPIA) and spot
5503 (INMT) in comparison to the OVX group.
Combined effects of both isoflavone supplementation
and exercise on the levels of hepatic protein expressions
in ovariectomized rats
Next, we examined if isoflavone supplementation and
exercise had a combined effect on the hepatic protein
expression profiles of ovariectomized rats (Figure 1B, C
and E). The OVX-increased protein levels of spot num-
ber 3607 (BUCS1) was decreased markedly in the ISO +
EXE group (3.12 fold down) whereas there were slight
decreases in the ISO and the EXE groups (1.81 and 1.75
fold down, respectively) compared with that of the SHAM
group. Similarly an elevation in the levels of spot 6601
(GAMT) in the OVX group (2.57 fold up compared to the
SHAM) was decreased with a greater extent in the ISO +
EXE group (0.63 fold down compared to the OVX) than
those in either the ISO or the EXE. The ISO + EXE alone
decreased the OVX-upregulated levels of spot number
5701 (PSME2) (2.15 fold down compared to the OVX).
The OVX-increased protein levels of spot numbers 8002
(AKR1C3) were further elevated both in the ISO (1.57 fold
up) and the EXE groups (2.11 fold up) but the ISO + EXE
lowered the ISO or EXE-elevated levels of AKR1C3. The
OVX-elevated expression levels of spot number 8203
(PPIA, 2.83 fold up compared to the SHAM) was slightly
further increased in the ISO + EXE group (1.34 fold up
compared to the OVX). On the other hand, spot number
9801 (OTC), which was down-regulated in the OVX, was
elevated in the ISO + EXE group (1.53 fold up) but not as
much as those in the ISO (2.95 fold up) and the EXE (2.26
fold up) compared to the OVX. The OVX-decreased
levels of spot number 9401 (ALDH2) was not affected in
the ISO but exhibited further reduction in the ISO + EXE
group (2.95 fold down compared to the OVX), which was
similar to the levels of the EXE.
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Since the liver is the primary organ for processing nutri-
ents, hormones, and drugs, we studied hepatic protein
changes induced by ovariectomization in 30-week-old fe-
male rats employing proteomic tools. We also elucidated
that ovariectomy-induced hepatic protein changes were
effectively restored through a combination of isoflavone
supplementation and exercise, which could benefit to
combat the health conditions related to the loss of estrogen
including the menopausal metabolic syndrome and osteo-
porosis. After ovariectomies, we identified that the proteins
BUCS1, PSME2, AKR1C3, GAMT, OTC, ALDH2, PPIA,
and INMT were differentially expressed in rat livers. These
expression levels except INMT were further affected by
isoflavone and/or exercise training.
BUCS1 is a mitochondrial enzyme that adds CoA to
medium chain fatty acids for oxidative degradation and
catalyzes the amino acid conjugation of many xenobiotic
acids [26-28]. Elevated levels of BUCS1 in ovariecto-
mized rats were dramatically reduced to the levels ob-
served in the SHAM group by the combined regime of
an isoflavone diet and exercise. The isoflavone diet and
exercise demonstrated a slight reduction in the BUCS1
protein levels. It appears that the combinatory regimen
of isoflavone diet and exercise seemed to be more effective
than either intervention alone in blocking the abnormal
activation of the oxidation of mitochondrial medium chain
fatty acids resulting from the loss of estrogen.
PSME2, also known as proteasome activator (PA) 28
beta subunit, is part of the PA28αβ proteasome regula-
tors found in immunoproteasomes [29] and has been
implicated in the removal of proteins modified by oxida-
tive stress [30]. A significant increase in the PSME2 pro-
tein levels in ovariectomized rats might indicate that the
loss of estrogen increased the levels of proteins that were
modified by oxidative stress. Indeed oxidative stress was
reported to increase the expression levels of PA28αβ
proteasome regulators [30]. Exercise alone further in-
duced higher levels of PSME2 protein compared to what
was observed in ovariectomized animals, which could in-
dicate that exercise provided additional oxidative stress
to the ovariectomized condition. While isoflavone intake
did not change PSME2 protein levels, an abrupt reduc-
tion of PSME2 protein was observed when an isoflavone
diet and exercise regimen was combined. It appears that
isoflavone supplementation may be effective in decreas-
ing oxidative stress in postmenopausal women who also
regularly partake in physical exercise.
AKR1C3 (aldo-keto reductase family 1 member 3) is
known to have steroid dehydrogenase activity (3α-HSD2,
17β-HSD5) [31], leading to the production of potent
forms of testosterone and 17β-estradiol [31-33]. Further-
more, the over-expression of AKR1C3 was shown to be
correlated with adiposity [34] and the size of the adipocyte[35]. The up-regulation of AKR1C3 in ovariectomized ani-
mals in comparison to the sham-operated animals might
be a consequence of compensatory mechanism to increase
the activity of sex hormones as a result of lack of estrogen
and indicate an increased adiposity. Both an isoflavone
diet and exercise further elevated AKR1C3 protein ex-
pression in ovariectomized rats. Interestingly the over-
expression of AKR1C3 in the ISO and the EXE groups
were reduced through a combined regimen of an isofla-
vone diet and exercise, thus avoiding the adverse effects of
the hyper-activation of AKR1C3.
GAMT is an enzyme that catalyzes the methylation
of guanidinoacetate acid, generating creatine and S-
adenosylhomocysteine [36]. GAMT also plays a role
in maintaining low levels of guanidinoacetate which
is neurotoxic [37]. The overiectomy-induced increase
in GAMT protein might be a protective mechanism
to remove guanidinoacetate which could be increased
by an estrogen-deficient condition. The reduction of
ovariectomy-increased GAMT levels by exercise and
further through the combination of isoflavone supplemen-
tation and exercise might indicate that the combined
regime was more effective to lower the levels of qua-
nidinoacetate followed by a reduction of GAMT than
either exercise or isoflavone supplementation.
OTC is an ornithine carbamoyltransferase, a key en-
zyme in the urea cycle for removing ammonia, a bypro-
duct of the breakdown of proteins in the body [38,39].
Compared to the SHAM group, the ovariectomized rats
demonstrated a significant reduction in OTC protein
abundance, which is consistent with the fact that OTC
expression is regulated by estrogen at the transcriptional
level [40]. In the present study, isoflavone supplementa-
tion or exercise alone significantly recovered OTC levels
in ovariectomized rats to about 50% of that observed in
the SHAM rats. This may suggest that either interven-
tion is beneficial for maintaining the levels of OTC pro-
tein. Overall, the effects of an isoflavone diet and exercise
on OTC protein expression seem to be beneficial.
PPIA acts as a molecular chaperone in protein folding
and catalyzes the interconversion of peptidyl-prolyl imide
bonds in peptide and protein substrates. The ovariectomy
induced expression of PPIA was further increased by an
isoflavone diet but was not affected by exercise, suggesting
that the protective protein chaperone function might be
induced by the loss of estrogen and further by isoflavone
supplementation.
ALDH2 plays a crucial role in metabolizing acetaldehyde
to acetic acid in the liver. ALDH2 protein reduces hepato-
toxicity by decreasing the levels of acetaldehyde [41]. Defi-
ciency in ALDH2 function caused the accumulation of lipid
oxidants and osteoporosis [42]. ALDH2 protein levels re-
duced in the ovariectomized rats were further reduced in
both the EXE and ISO+ EXE groups. However, isoflavone
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sity. Thus, it appeared that exercise alone lowered ALDH2
protein expression in ovariectomized rats. Therefore, the
loss of estrogen might increase acetaldehyde levels, result-
ing in an increased risk of oxidative stress and osteoporosis
partly through the loss of ALDH2 protein levels. Exercise
may reinforce the menopause-induced deficiency of
ALDH2 protein levels.
INMT methylates tryptamine and structurally similar
compounds [43]. Methylation is considered to be important
in metabolizing endogenous and exogenous molecules such
as drugs [43]. In the present study, the INMT protein spot
was not detected in all of the ovariectomized groups. Nei-
ther isoflavone supplementation nor exercise was effective
in recovering INMT protein expression. The absence of the
INMT protein spot in the ovariectomized animals may in-
dicate that estrogen is required for INMT expression and
loss of estrogen hinder the methylation of tryptamine and
related products due to insufficient INMT levels.
Conclusions
Our proteomic data suggest that ovariectomy-induced
changes in hepatic protein expression can be modulated
by isoflavone supplementation or exercise. We have iden-
tified seven proteins differentially expressed depending on
the treatment utilized: PPIA, AKR1C3, ALDH2, PSME2,
BUCS1, OTC, and GAMT. The combination of an isofla-
vone diet and exercise was more effective in reversing the
changes in ovariectomy-induced hepatic protein ex-
pression than either intervention alone. Thus, for women
undergoing menopause, the combinatory regimen of iso-
flavone diet and exercise may be effective for adapting to a
new estrogen-deficient condition and for protecting the
body from stresses related to estrogen deprivation.
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